Tag: NCE
Veeda engages with life sciences startups for Phase 1 trial solutions
The registered participants at the Phase 1 symposium featured life sciences start-up companies from healthcare, biopharma, industrial biotech, agriculture, and med-tech fields.
CSIR’s anti-pancreatic cancer drug IIIM-290 gets approval for clinical trial
Approval from the New Drugs Division of Central Drugs Standard Control Organization (CDSCO) will pave way for CSIR-Indian Institute of Integrative Medicine (IIIM) Jammu for conducting the clinical trial of this important drug candidate IIIM-290 in pancreatic cancer patients....................
Exclusive: Apex committee on clinical trials takes steps to streamline regulations
The issues related to streamlining of approvals to clinical trials were discussed and appropriate modifications were given green signal by the top health regulatory officials at their 34th apex committee meeting held recently at Delhi.........
Eyeing big dermatology market, Vyome Biosciences raises $14 million fresh funding
As a result of funding, the company's lead program VB 1953, targeting the large unmet need of antibiotic-resistant acne is expected to.....